Research Site

Jordan 999077

1 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non- Small Cell Lung, Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Stage III Non-small Cell Lung Cancer, Unresectable

Studies at this site

• Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer — Recruiting now
• A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations — Running, not enrolling
• Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC — Completed
• Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy. — Completed